局部格劳科马药物 - 对梅博米腺的可能影响
Fredrik Fineide1,2,3,4, Morten Magnø1,5,6,7, Kristian Dahlø8
1Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
Acta ophthalmologica
|June 1, 2024
概括
青光眼滴,特别是那些含有防腐剂的眼滴,可以损害对眼睛健康至关重要的梅博米腺. 没有防腐剂的选择可能不那么有害,但仍然会影响腺体功能.
科学领域:
- 眼科医生 眼科 眼科
- 眼睛表面疾病 眼睛表面疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 青光眼是导致失明的主要原因,主要通过使用局部眼滴降低眼内压力 (IOP) 来控制.
- 梅博姆腺对催膜的稳定性至关重要;它们的功能障碍导致干眼疾病.
- 人们担心,青光眼的药物和防腐剂会损害梅博米腺和眼睛表面.
研究的目的:
- 审查关于降低内血压的眼滴如何影响梅博米腺功能和眼睛表面健康的证据.
- 为了比较防腐剂与无防腐剂格劳科马药物的对梅博米腺的影响.
主要方法:
- 对调查局部格劳科马治疗对梅博米腺的影响的研究的文献综述.
- 临床和实验数据分析与眼睛表面变化相关的绿眼病眼滴.
主要成果:
- 保存的玻璃眼滴与梅博米腺功能障碍,缩和脱落有关.
- 与没有防腐剂的替代品相比,防腐剂配方会加剧眼睛干燥症状,眼膜不稳定性和眼睛炎症.
- 未保存的青光眼药物,虽然潜在的危害较小,但也可能损害梅博米腺的疗效或导致细胞死亡.
结论:
- 局部治疗青光眼的药物,特别是保存药物,可能会对梅博米腺的结构和功能产生不利影响.
- 这种损伤可能会对患者的生活质量,治疗坚持以及青光眼管理结果产生负面影响.
- 需要进行进一步的研究,以优化对眼睛表面健康的玻璃眼治疗策略.
相关概念视频
Open Angle Glaucoma: Treatment
427
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
427
Glaucoma: Overview
541
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
541
Angle Closure Glaucoma: Treatment
473
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
473
Cholinergic Antagonists: Pharmacokinetics
432
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
432
Direct-Acting Cholinergic Agonists: Therapeutic Uses
726
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
726
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.3K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.3K


